Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Short term Debt (2010 - 2024)

AtriCure (ATRC) reported Short term Debt of $2.8 million for Q4 2024, up 10.74% year-over-year from $2.5 million in Q1 2024, and up 10.74% on a QoQ basis from $2.5 million in Q4 2023.

AtriCure (ATRC) has 12 years of Short term Debt data on file, last reported at $2.8 million in Q4 2024.

  • Quarterly Short term Debt rose 10.74% year-over-year to $2.8 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $2.8 million (up 10.74% YoY) and the FY2024 annual result came in at $2.8 million, up 10.74% from the prior year.
  • Short term Debt climbed to $2.8 million in Q4 2024 per ATRC's latest filing, from $2.5 million in the prior quarter.
  • Across five years, Short term Debt topped out at $5.5 million in Q4 2022 and bottomed at $2.5 million in Q4 2023.
  • The 3-year median for Short term Debt is $2.8 million (2024), against an average of $3.6 million.
  • The widest annual swing landed in 2023, when Short term Debt tumbled 53.71%; it then increased 10.74% in 2024.
  • Tracing ATRC's Short term Debt over 3 years: stood at $5.5 million in 2022, then plunged by 53.71% to $2.5 million in 2023, then climbed by 10.74% to $2.8 million in 2024.
  • Per Business Quant, the three latest ATRC Short term Debt figures stand at $2.8 million (Q4 2024), $2.5 million (Q4 2023), and $5.5 million (Q4 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 AtriCure 1.39 Bn 1.25 Bn 109.31 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 2.81 Mn
Dec 31, 2023 2.53 Mn
Dec 31, 2022 5.47 Mn
Sep 30, 2018 1.56 Mn
Jun 30, 2018 1.56 Mn
Mar 31, 2018 575,000.00
Dec 31, 2017 561,000.00
Sep 30, 2017 7.09 Mn
Jun 30, 2017 5.29 Mn
Mar 31, 2017 3.49 Mn
Dec 31, 2016 1.69 Mn
Dec 31, 2015 450,000.00
Dec 31, 2014 3.98 Mn
Sep 30, 2014 2.54 Mn
Jun 30, 2014 41,000.00
Mar 31, 2014 38,000.00
Dec 31, 2013 2.04 Mn
Sep 30, 2013 2.04 Mn
Jun 30, 2013 2.03 Mn
Dec 31, 2012 2.03 Mn
Sep 30, 2012 2.03 Mn
Jun 30, 2012 2.04 Mn
Mar 31, 2012 2.04 Mn
Dec 31, 2011 1.54 Mn
Sep 30, 2011 1.53 Mn
Jun 30, 2011 1.53 Mn
Dec 31, 2010 2.19 Mn